• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 69-83 of 321 results

No. 11

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 11 (N.D.W.Va. Mar. 28, 2022)

cite Cite Document
Analyze

No. 2

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2 (N.D.W.Va. Mar. 18, 2022)

cite Cite Document
Analyze

10 Other Refund request: Petitioners Request for Refund of Post Institution Fees

Document IPR2023-00723, No. 10 Other Refund request - Petitioners Request for Refund of Post Institution Fees (P.T.A.B. Dec. 14, 2023)

cite Cite Document
Analyze

No. 31

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 31 (N.D.W.Va. May. 24, 2022)

cite Cite Document
Analyze

No. 30

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 30 (N.D.W.Va. May. 24, 2022)

cite Cite Document
Analyze

No. 27

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 27 (N.D.W.Va. May. 16, 2022)

cite Cite Document
Analyze

RYBELSUS

Docket 213051, Orange Book (Sept. 20, 2019)

cite Cite Docket
Analyze

No. 25

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 25 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 26

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 26 (N.D.W.Va. May. 11, 2022)

cite Cite Document
Analyze

No. 22

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22 (N.D.W.Va. May. 6, 2022)

cite Cite Document
Analyze

No. 20

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 20 (N.D.W.Va. Apr. 8, 2022)

cite Cite Document
Analyze

No. 13

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 13 (N.D.W.Va. Mar. 28, 2022)

cite Cite Document
Analyze

No. 1

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 1 (N.D.W.Va. Mar. 18, 2022)

cite Cite Document
Analyze

No. 6

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 6 (N.D.W.Va. Mar. 18, 2022)

cite Cite Document
Analyze

No. 3

Document Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 3 (N.D.W.Va. Mar. 18, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 9 ... >>